Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

37.49
-1.8000-4.58%
Post-market: 37.490.00000.00%16:44 EDT
Volume:1.09M
Turnover:41.22M
Market Cap:3.54B
PE:-6.38
High:39.33
Open:38.34
Low:37.13
Close:39.29
Loading ...

Buy Rating on Ultragenyx Pharmaceutical: Promising Potential of Setrusumab for Osteogenesis Imperfecta and Attractive Risk/Reward Profile

TIPRANKS
·
11 Jun

Ultragenyx Pharmaceutical (RARE) Receives a New Rating from William Blair

TIPRANKS
·
31 May

RBC Capital Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
30 May

Ultragenyx Pharmaceutical Inc : William Blair Initiates Coverage With Outperform Rating

THOMSON REUTERS
·
28 May

William Blair Initiates Ultragenyx Pharmaceutical at Outperform

MT Newswires Live
·
28 May

Ultragenyx initiated with an Outperform at William Blair

TIPRANKS
·
28 May

J.P. Morgan Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
23 May

Ultragenyx Announces Grant of Restricted Stock Units to New Employees Under Inducement Plan

Reuters
·
21 May

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
21 May

Ultragenyx Pharmaceutical Approves Key Proposals at Annual Meeting

TIPRANKS
·
20 May

Ultragenyx Pharmaceutical Inc. Conducted Annual Stockholders Meeting

Reuters
·
20 May

Ultragenyx Pharma Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
10 May

Evercore ISI Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
08 May

Stock Track | Ultragenyx Pharmaceutical Plunges 5% as Truist Securities Slashes Price Target

Stock Track
·
07 May

Stock Track | Ultragenyx Pharmaceutical (RARE) Soars 5.53% Pre-market Following Positive Analyst Ratings

Stock Track
·
07 May

Stock Track | Ultragenyx Pharmaceutical (RARE) Soars 5.53% Pre-market on Bullish Analyst Ratings

Stock Track
·
07 May

Ultragenyx Pharmaceutical (RARE) Gets a Buy from Wells Fargo

TIPRANKS
·
07 May

Ultragenyx Pharmaceutical (RARE) Receives a Buy from Barclays

TIPRANKS
·
07 May

Ultragenyx Pharmaceutical Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Stock Track | Ultragenyx Pharmaceutical Plummets 9.94% Following Q1 2025 Results Despite Narrower-Than-Expected Loss

Stock Track
·
07 May